Nucleic acid probes and methods for detecting clinically important fungal pathogens
US6858387B1 · kind B1 · utility
25Cited by
14References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 15, 2000 |
| Grant date | Feb 22, 2005 |
| Priority date | — |
| Expiry date | Sep 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/6895
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The current invention relates to the field of detection and identification of clinically important fungi. More particularely, the present invention relates to species specific probes originating from the Internal Transcribed Spacer (ITS) region of rDNA for the detection of fungal species such as Candida albicans, Candida parapsilosis, Candida tropicalis, Candida kefyr, Candida krusei, Candida glabrata, Candida dubliniensis, Aspergillus flavus, Aspergillus versicolor, Aspergillus nidulans, Aspergillus fumigatus, Cyptococcus neoformans and Pneumocystis carinii in clinical samples, and methods using said probes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.